Bhate Hospital stands for excellence in medical care with over 30 years of trust and commitment to patient health.
Bhate Multi-Speciality Hospital, Belagavi, was selected as an official clinical trial center for Covaxin (BBV152) — India’s indigenous COVID vaccine developed by Bharat Biotech in collaboration with ICMR.
Our team played a critical role in the successful execution of vaccine trials through rigorous adherence to national research protocols.
Expert screening, selection, and recruitment of volunteers for the clinical trials.
Comprehensive RT-PCR testing and detailed blood investigations for all participants.
Precise vaccine administration following strict safety and storage protocols.
Continuous monitoring for adverse effects and immediate emergency preparedness.
Diligent follow-up to track and document immune responses over time.
Seamless coordination with Bharat Biotech and ICMR research protocols.
Our commitment to medical advancement extends beyond the initial Covaxin trials. Bhate Multi-Speciality Hospital has been actively involved in several other landmark studies:
This contribution placed Bhate Multi-Speciality Hospital, Belagavi, among the recognized centers contributing to India’s pandemic response and vaccine research efforts.
Strict Approvals
Monitoring Systems
Research Teams
Protocol Compliance
Very few private hospitals from smaller cities were selected for India’s COVID vaccine clinical research programs. Participation required the highest standards of ethics, infrastructure, and clinical expertise.
Bhate Hospital is committed to providing ethical, reliable, and high-quality healthcare services. Our accreditations reflect our unwavering dedication to patient safety.
Accredited
Certified
Recognized
Investigator
24
Hour Emergency Aid